PETV on OTC
PetVivo Holdings, Inc.
American surgical and medical instruments and apparatus company. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with RenovoRx, Inc., SeaStar Medical Holding Corp or Sintx Technologies, Inc., or pick any stock.
- TickerPETV on OTC1
- IndustrySurgical & Medical Instruments & Apparatus1
- HeadquartersEdina, Minnesota1
- Incorporated inNV3
- Business address5251 Edina Industrial Blvd, Edina, Mn 554393
- Filer category, Emerging growth company3
See how the biggest companies compare on our leaderboards
Agreement”), to market, distribute and sell the Company’s products in the United States, including the District of Columbia.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Sales to Vedco brought in 95% of the revenue PetVivo Holdings, Inc. broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2025 | 2026 |
|---|---|---|
| Sales to Vedco | $288.9K | $809.2K |
| Sales To Clipper | $194.5K | $40.5K |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue21¢$386.9K
- Research and development78¢$1.4M
- Interest1¢$12.7K
Out of $1.1M in revenue.2 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Revenues | $1.1M | $1.1M |
| Cost of Sales | $386.9K | $137.7K |
| Gross Profit | $754.8K | $994.9K |
| Sales and Marketing | $3.1M | $2.6M |
| Research and Development | $1.4M | $1.6M |
| General and Administrative | $4.3M | $4.8M |
| Impairment Expense | $1.0M | |
| Total Operating Expenses | $9.8M | $9.1M |
| Operating Loss | -$9.1M | -$8.1M |
| Loss on Disposal of Assets | -$149.1K | |
| Gain on Extinguishment of debt | $66.1K | |
| Unrealized Loss on Change in Derivative Liabilities | -$320.4K | -$106.5K |
| Other Income | $111.5K | $56.4K |
| Interest Income | $13.1K | |
| Interest Expense | -$1.1M | -$359.4K |
| Total Other Income (Expense) | -$1.4M | -$343.4K |
| Loss before taxes | -$10.5M | -$8.4M |
| Net Loss | -$10.5M | -$8.4M |
| Less: Series B Preferred Stock Dividends | -$403.6K | |
| Net Loss Available to Common Stockholders | -$10.9M | -$8.4M |
| Basic | -$0.38 | -$0.41 |
| Diluted | -$0.38 | -$0.41 |
| Basic | 30.2M shares | 20.5M shares |
| Diluted | 30.2M shares | 20.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2026-03-31 | 2025-06-30 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|---|
| Cash | $200.8K | $227.7K | ||
| Accounts receivable, net of allowance for credit losses | $100.8K | $60.6K | ||
| Subscriptions receivable | $600.0K | $4.4M | ||
| Inventory, net of allowances (Note 2) | $538.4K | $323.5K | ||
| Investments | $150.0K | $150.0K | ||
| Prepaid expenses and other current assets (Note 3) | $269.9K | $447.8K | ||
| Total Current Assets | $1.9M | $5.6M | ||
| Property and Equipment, net (Note 4) | $448.9K | $766.9K | ||
| Operating lease right-of-use | $54.7K | $891.0K | $961.5K | |
| Patents and trademarks, net (Note 5) | $20.5K | $23.7K | ||
| Licensing Agreements, net (Note 6) | $1.2M | $1.9M | ||
| Security deposit | $12.8K | $27.5K | ||
| Total Other Assets | $1.3M | $3.0M | ||
| Total Assets | $3.6M | $9.3M | ||
| Accounts payable | $547.4K | $821.1K | ||
| Accrued expenses (Note 7) | $453.7K | $948.6K | ||
| Operating lease liability current portion | $54.7K | $163.8K | ||
| Notes payable and accrued interest-current portion (Note 8) | $321.4K | $312.9K | ||
| Convertible notes payable and accrued interest, net of debt discount of $0 and $149,644 (Note 9) | $1.6M | |||
| Derivative liabilities | $448.1K | |||
| Total Current Liabilities | $1.4M | $4.3M | ||
| Operating lease liabilities (net of current portion) | $797.7K | |||
| Notes payable and accrued interest (net of current portion) (Note 8) | $5.4K | |||
| Total Other Liabilities | $803.1K | |||
| Total Liabilities | $1.4M | $5.1M | ||
| Common stock, par value $0.001 per share, 250,000,000 shares authorized, 35,849,919 and 24,181,537 shares issued and outstanding at March 31, 2026 and 2025 | $35.9K | $24.2K | ||
| Common stock to be issued | $649.8K | |||
| Additional Paid-In Capital | $103.6M | $95.4M | ||
| Accumulated Deficit | -$102.1M | -$91.2M | ||
| Total Stockholders Equity | $2.2M | $4.2M | $686.0K | |
| Total Liabilities and Stockholders Equity | $3.6M | $9.3M | ||
| Convertible notes payable and accrued interest, discount | $0 | $149.6K | ||
| Preferred stock, par value | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 20.0M shares | 20.0M shares | ||
| Common stock, par value | $0.00 | $0.00 | ||
| Common stock, shares authorized | 250.0M shares | 250.0M shares | ||
| Common stock shares issued | 35.8M shares | 24.2M shares | ||
| Common stock, shares outstanding | 35.8M shares | 24.2M shares |
| Period ending | 2026-03-31 | 2025-06-30 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|---|
| Cash | $200.8K | $227.7K | ||
| Accounts receivable, net of allowance for credit losses | $100.8K | $60.6K | ||
| Subscriptions receivable | $600.0K | $4.4M | ||
| Inventory, net of allowances (Note 2) | $538.4K | $323.5K | ||
| Investments | $150.0K | $150.0K | ||
| Prepaid expenses and other current assets (Note 3) | $269.9K | $447.8K | ||
| Total Current Assets | $1.9M | $5.6M | ||
| Property and Equipment, net (Note 4) | $448.9K | $766.9K | ||
| Operating lease right-of-use | $54.7K | $891.0K | $961.5K | |
| Patents and trademarks, net (Note 5) | $20.5K | $23.7K | ||
| Licensing Agreements, net (Note 6) | $1.2M | $1.9M | ||
| Security deposit | $12.8K | $27.5K | ||
| Total Other Assets | $1.3M | $3.0M | ||
| Total Assets | $3.6M | $9.3M | ||
| Accounts payable | $547.4K | $821.1K | ||
| Accrued expenses (Note 7) | $453.7K | $948.6K | ||
| Operating lease liability current portion | $54.7K | $163.8K | ||
| Notes payable and accrued interest-current portion (Note 8) | $321.4K | $312.9K | ||
| Convertible notes payable and accrued interest, net of debt discount of $0 and $149,644 (Note 9) | $1.6M | |||
| Derivative liabilities | $448.1K | |||
| Total Current Liabilities | $1.4M | $4.3M | ||
| Operating lease liabilities (net of current portion) | $797.7K | |||
| Notes payable and accrued interest (net of current portion) (Note 8) | $5.4K | |||
| Total Other Liabilities | $803.1K | |||
| Total Liabilities | $1.4M | $5.1M | ||
| Common stock, par value $0.001 per share, 250,000,000 shares authorized, 35,849,919 and 24,181,537 shares issued and outstanding at March 31, 2026 and 2025 | $35.9K | $24.2K | ||
| Common stock to be issued | $649.8K | |||
| Additional Paid-In Capital | $103.6M | $95.4M | ||
| Accumulated Deficit | -$102.1M | -$91.2M | ||
| Total Stockholders Equity | $2.2M | $4.2M | $686.0K | |
| Total Liabilities and Stockholders Equity | $3.6M | $9.3M | ||
| Convertible notes payable and accrued interest, discount | $0 | $149.6K | ||
| Preferred stock, par value | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 20.0M shares | 20.0M shares | ||
| Common stock, par value | $0.00 | $0.00 | ||
| Common stock, shares authorized | 250.0M shares | 250.0M shares | ||
| Common stock shares issued | 35.8M shares | 24.2M shares | ||
| Common stock, shares outstanding | 35.8M shares | 24.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Net Loss | -$10.5M | -$8.4M |
| Stock-based compensation | $1.9M | $1.1M |
| Depreciation and amortization | $511.5K | $174.6K |
| Amortization of Right-of-Use Asset | $31.4K | $178.6K |
| Unrealized loss on change in fair value of derivatives | $320.4K | $290.6K |
| Loss on disposal of fixed assets | $149.1K | |
| Loss on impairment of licensing agreement | $1.0M | |
| Loss on write down of inventory | $239.9K | |
| Amortization of debt discount | $936.6K | $106.5K |
| Common stock issued for services | $192.7K | $574.3K |
| Stock issued in lieu of compensation, net of cancelled shares | $359.5K | |
| Common stock issued for stock option buyout program | $72.8K | |
| Gain on extinguishment of debt | -$66.1K | |
| Loss on sale of lease vehicles | $1.0K | |
| (Increase) decrease in prepaid expenses and other assets | $177.9K | $97.7K |
| (Increase) decrease in accounts receivable | -$45.1K | -$41.9K |
| (Increase) decrease in inventory | -$454.8K | $66.6K |
| (Decrease) increase in accounts payable and accrued expenses | -$649.0K | $271.4K |
| Lease liabilities | -$31.4K | -$179.6K |
| Accrued interest in notes payable | $107.4K | $63.6K |
| Net Cash (Used In) Operating Activities | -$6.1M | -$5.3M |
| Purchase of property and equipment | -$7.7K | -$63.4K |
| Payments received on disposal of equipment | $4.9K | |
| Payments made on licensing agreement | -$500.0K | |
| Security deposits | $14.7K | |
| Net Cash Provided by (Used In) Investing Activities | $11.8K | -$563.4K |
| Proceeds from the sale of common stock and warrants | $675.0K | $2.1M |
| Proceeds from exercise of warrants | $1.8M | |
| Proceeds from preferred stock subscription receivable | $4.4M | |
| Proceeds from the issuance of convertible debentures | $160.0K | $1.9M |
| Proceeds from the exercise of warrants | $851.8K | |
| Proceeds from the issuance of notes payable | $332.0K | $300.0K |
| Repayments of notes payable | -$350.2K | -$7.4K |
| Net Cash Provided by Financing Activities | $6.1M | $6.0M |
| Net increase (decrease) in Cash | -$26.9K | $140.3K |
| Interest | $21.8K | $8.4K |
| Derecognition and decrease of operating lease right-of-use asset and lease liability | -$891.0K | |
| Common stock issued on conversion of convertible notes and accrued interest | $2.0M | $301.6K |
| (Decrease) increase to operating lease right of use asset and operating lease liabilities | -$53.2K | |
| Vesting of restricted stock units | $175 | $428 |
| Stock issued for conversion of accounts payable | $6.0K | |
| Dividends declared on Series B preferred stock | $403.6K | |
| Stock issued for conversion of accrued dividends | $278.6K | |
| Stock issued for licensing agreement | $800.0K | $1.0M |
| Stock issued for investment | $150.0K | |
| (Decrease) increase to accrued expenses for licensing agreement | -$125.0K | $500.0K |
| Warrants issued as debt discount | $98.7K | |
| Derivative liabilities as debt discount | $341.6K | |
| Stock to be issued for common stock subscription receivable | $600.0K | |
| Preferred stock subscription | $4.4M |
No quarter-by-quarter statement was filed.
Leadership
Who has led PetVivo Holdings, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
Chief operating officer
- Chief executive officerWesley Hayne Sep 19, 2018 to Sep 19, 201814
- Chief executive officerJohn Lai Mar 28, 2014 to Sep 19, 201815
- ChairJohn Lai Sep 19, 2018 to Sep 19, 201816
- PresidentDavid B. Masters Jun 8, 2015 to Jun 8, 201517
- PresidentJohn Lai Mar 28, 2014 to Sep 19, 202415
- Chief financial officerGarry N. Lowenthal Mar 20, 2024 to Oct 18, 202418
- Chief financial officerDiane M. Levitan Oct 18, 2024 to Oct 18, 202419
- Chief financial officerJohn Spencer Breithaupt Oct 18, 2024 to Oct 18, 202420
- Chief financial officerJoseph William Jasper Oct 18, 2024 to Oct 18, 202421
- Chief financial officerMichael Eugene Eldred Oct 18, 2024 to Oct 18, 202422
- Chief financial officerRobert J. Costantino Oct 18, 2024 to Oct 18, 202423
- Chief financial officerRobert James Rudelius Oct 18, 2024 to Oct 18, 202424
- Chief financial officerRobert J. Folkes May 3, 2021 to Oct 20, 202225
- Chief financial officerJohn Michael Carruth Jun 4, 2019 to Sep 22, 202026
- Chief financial officerJohn Lai Sep 19, 2018 to Sep 19, 201816
- Chief financial officerJohn F. Dolan Mar 28, 2014 to Aug 20, 201427
- Chief operating officerJohn Lai Sep 10, 2021 to Sep 10, 202128
- Chief operating officerRandall A. Meyer Jun 8, 2015 to Sep 19, 202429
Board members and other officers (20)
- SecretaryJohn F. Dolan Nov 18, 2019 to Sep 19, 202430
- Board memberJoshua David Ruben Nov 19, 2025 to now31
- Board memberMichael Eugene Eldred Oct 8, 2024 to now32
- Board memberJohn Spencer Breithaupt Apr 17, 2023 to now33
- Board memberDiane M. Levitan Nov 21, 2023 to now34
- Board memberLeslie Anne Coolidge Aug 4, 2022 to Oct 24, 202235
- Board memberRobert J. Costantino Aug 4, 2022 to now36
- Board memberGregory D. Cash Aug 20, 2019 to Jul 7, 202237
- Board memberScott Mitchell Johnson Aug 20, 2019 to Oct 24, 202238
- Board memberSherry Grisewood Sep 14, 2018 to Feb 21, 201939
- Board memberDavid Don Deming Sep 19, 2018 to May 4, 202240
- Board memberJoseph William Jasper Sep 19, 2018 to now41
- Board memberWesley Hayne Sep 19, 2018 to Sep 19, 201814
- Board memberDavid Edward Merrill Sep 20, 2018 to Feb 21, 201942
- Board memberRobert James Rudelius Sep 20, 2018 to now43
- Board memberPeter Vezmar Oct 17, 2018 to Mar 18, 201944
- Board memberRandall A. Meyer Jun 8, 2015 to Sep 10, 202129
- Board memberDavid B. Masters Mar 28, 2014 to Oct 4, 202145
- Board memberJohn F. Dolan Mar 28, 2014 to Sep 10, 202127
- Board memberJohn Lai Mar 28, 2014 to now15
Former names
- Technologies Scan CorpApr 18, 2011 to May 2, 20143
Timeline
Filings
327 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 97 major events, 145 insider forms, 39 large holders, 25 other. The latest 20:
- Sep 22, 20268-K EDGAR
- Sep 22, 20268-K EDGAR
- Sep 21, 20264 EDGAR
- Sep 15, 2026SCHEDULE 13D/A EDGAR
- Sep 15, 20264 EDGAR
- Sep 11, 20264/A EDGAR
- Sep 11, 20264/A EDGAR
- Sep 10, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Aug 20, 20268-K EDGAR
- Aug 14, 202610-Q EDGAR
- Aug 5, 2026SCHEDULE 13G EDGAR
- Jul 29, 20268-K EDGAR
- Jul 27, 20268-K EDGAR
- Jul 22, 20264 EDGAR
- Jul 22, 20264 EDGAR
- Jun 29, 202610-K EDGAR
- Jun 25, 20268-K EDGAR
- Jun 11, 20268-K EDGAR
- Jun 11, 20264 EDGAR
The 327 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
159 open-market trades by officers, directors and large owners since October 2021: 159 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | A.L. Sarroff Fund, LLC10% owner | Buy | 24,888 | $0.69 | $17.2K | Form 4 |
| Sep 10, 2026 | A.L. Sarroff Fund, LLC10% owner | Buy | 10,974 | $0.68 | $7.5K | Form 4 |
| Sep 9, 2026 | A.L. Sarroff Fund, LLC10% owner | Buy | 22,160 | $0.68 | $15.1K | Form 4 |
| Aug 27, 2026 | A.L. Sarroff Fund, LLC10% owner | Buy | 580 | $0.69 | $400 | Form 4 |
| Jun 9, 2026 | A.L. Sarroff Fund, LLC10% owner | Buy | 187,500 | Form 4 | ||
| May 22, 2026 | A.L. Sarroff Fund, LLC10% owner | Buy | 250,000 | $0.40 | $100.0K | Form 4 |
| Mar 23, 2026 | A.L. Sarroff Fund, LLC10% owner | Buy | 24,033 | $0.68 | $16.4K | Form 4 |
| Mar 13, 2026 | A.L. Sarroff Fund, LLC10% owner | Buy | 1,250,000 | Form 4 | ||
| Dec 26, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 2,400 | $1.16 | $2.8K | Form 4 |
| Dec 24, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 14,632 | $1.09 | $15.9K | Form 4 |
| Dec 16, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 7,700 | $1.15 | $8.9K | Form 4 |
| Dec 12, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 1,100 | $1.14 | $1.3K | Form 4 |
| Dec 11, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 10,000 | $1.17 | $11.7K | Form 4 |
| Dec 10, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 6,700 | $1.14 | $7.6K | Form 4 |
| Dec 9, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 5,100 | $1.11 | $5.7K | Form 4 |
| Dec 8, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 8,154 | $1.05 | $8.6K | Form 4 |
| Dec 5, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 21,571 | $1.10 | $23.8K | Form 4 |
| Dec 2, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 1,000 | $1.13 | $1.1K | Form 4 |
| Nov 21, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 127,250 | $0.95 | $120.9K | Form 4 |
| Nov 20, 2025 | A.L. Sarroff Fund, LLC10% owner | Buy | 20,000 | $1.10 | $22.0K | Form 4 |
All 159 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- A.L. Sarroff Fund, LLCSCHEDULE 13D/A, 15 filings Aug 21, 2023 to Sep 15, 202646
- Alex NazarenkoSCHEDULE 13G, 2 filings Nov 4, 2024 to Aug 5, 202647
- Stanley C. CrudenSCHEDULE 13G/A, 19 filings Jan 28, 2022 to Jan 20, 202648
- John F. DolanSC 13D/A, 1 filing Jun 23, 202249
- John LaiSC 13D/A, 1 filing Jun 23, 202250
- Randall A. MeyerSC 13D, 1 filing Jun 23, 202251
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Vermillion Wealth Management, Inc. | 48,100 | $40.4K | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARJohn Lai, Chief executive officer
- 16SEC EDGARJohn Lai, Chair
- 17SEC EDGARDavid B. Masters, President
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28SEC EDGARJohn Lai, Chief operating officer
- 29
- 30SEC EDGARJohn F. Dolan, Secretary
- 31SEC EDGARJoshua David Ruben, Board member
- 32SEC EDGARMichael Eugene Eldred, Board member
- 33
- 34SEC EDGARDiane M. Levitan, Board member
- 35SEC EDGARLeslie Anne Coolidge, Board member
- 36SEC EDGARRobert J. Costantino, Board member
- 37SEC EDGARGregory D. Cash, Board member
- 38SEC EDGARScott Mitchell Johnson, Board member
- 39SEC EDGARSherry Grisewood, Board member
- 40SEC EDGARDavid Don Deming, Board member
- 41SEC EDGARJoseph William Jasper, Board member
- 42SEC EDGARDavid Edward Merrill, Board member
- 43SEC EDGARRobert James Rudelius, Board member
- 44SEC EDGARPeter Vezmar, Board member
- 45SEC EDGARDavid B. Masters, Board member
- 46
- 47
- 48
- 49
- 50
- 51